Atlas Trials

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Clinical trial NCT07043218 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07043218
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
B-cell Acute Lymphoblastic Leukemia
Start date
2025-07-10
Primary completion
2026-06-30
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.